Phreesia Inc

Phreesia, Inc. is a healthcare software company, which engages in the provision of patient check-in solutions for medical practices. The firm offers appointments, clinical support, integration, registration, patient activation, analytics and reports, revenue cycle, patient surveys, and privacy and security products. Its solutions include health systems, multi-specialty, and federally qualified health centers (FQHCs). The company was founded by Chaim Indig and Evan Roberts in January 2005 and is headquartered in Wilmington, DE.

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

Earnings data Q4 2025

Phreesia reports strong Q1 earnings, sees growth in Medicare market

Phreesia's Q1 2023 earnings call highlighted strong performance, maintained revenue outlook, and raised adjusted EBITDA outlook. The company faces challenges from labor market changes and pricing experimentation but sees opportunities in product growth, client adds, and patient insights application.

Phreesia reports strong Q2 2024 earnings and strategic acquisitions

Phreesia's Q2 2024 performance reflects strong revenue growth and strategic outlook, despite challenges related to client adds and subscription revenue. The company's focus on achieving profitability beyond fiscal 2025 and strategic acquisitions positions it for long-term value creation. Balancing growth and investment, as well as navigating seasonality and external events, are key considerations for Phreesia's future.

Phreesia reports Q3 2024 revenue of $91.6 million, delays revenue target to prioritize EBITDA growth

Phreesia's Q3 2024 earnings call highlighted strong revenue performance, an acquisition enhancing patient experience, and a strategic decision to delay revenue targets to prioritize EBITDA growth. The company maintains a focus on innovation, customer satisfaction, and sustainable financial performance, while also addressing short-term financial challenges and positioning for significant revenue and profitability growth in fiscal 2025.

Phreesia reports robust Q4 earnings, eyes growth in healthcare solutions

Phreesia Inc's Q4 2023 performance reflects strong revenue growth and client base expansion, positioning the company for future profitability and stability.
With a focus on client value, strategic acquisitions, and operational efficiency, Phreesia navigates challenges in the healthcare industry to drive long-term growth.
Opportunities in network solutions, payer space, and margin improvement present avenues for Phreesia to capitalize on market trends and enhance shareholder value.

Phreesia Inc reports strong Q1 earnings, eyes revenue growth

Phreesia Inc's Q1 2024 performance reflects robust revenue growth and client expansion, with a positive outlook for fiscal 2024 and ambitious targets for fiscal 2025.
While facing challenges such as potential growth deceleration and labor market impacts, the company remains focused on innovation, client satisfaction, and profitability.
Opportunities in new revenue streams, partnerships, and payment technologies present avenues for Phreesia to drive future growth and market leadership.

Phreesia Inc reports robust Q2 performance and targets fiscal growth

Phreesia Inc's Q2 2024 earnings call highlighted strong revenue growth, improved EBITDA, and strategic targets for fiscal 2024 and 2025, underpinned by investments in client value and growth strategies.
While facing challenges in the sales cycle and cost controls, the company remains focused on achieving profitability and free cash flow without additional capital beyond fiscal '25.
Opportunities in product introductions, customer service enhancements, and market expansion present avenues for sustained growth and value creation for Phreesia.

Phreesia reports robust Q3 performance, shifts focus to profitability

Phreesia Inc's Q3 2024 earnings call highlighted strong revenue growth, improved EBITDA, and strategic acquisitions, underlining the company's positive trajectory.
While facing challenges in achieving profitability and managing investor expectations, Phreesia's focus on financial discipline and market expansion presents opportunities for sustainable growth.
The establishment of a new credit facility and clear guidance for fiscal 2024 and 2025 demonstrate Phreesia's commitment to financial stability and long-term value creation.

Phreesia reports strong Q4 revenue growth and focuses on profitability

Phreesia Inc's Q4 performance reflects revenue growth and improved EBITDA, with a focus on efficiency and client value to drive profitability.
Despite industry challenges, Phreesia's strengths in client growth strategies, network solutions revenue, and cash flow support its growth trajectory.
Balancing profitability goals with investments in growth, Phreesia navigates challenges while exploring opportunities in PAM, client value, and network expansion.
The company's outlook for FY 2025 underscores a commitment to sustainable growth through client additions, product enhancements, and operational efficiency.

Phreesia Inc reports strong Q1 earnings, eyes growth opportunities

Phreesia Inc's Q1 performance reflects a positive turnaround with revenue growth and adjusted EBITDA turning positive after 3 years. The company faces challenges from client relationship transitions but is leveraging opportunities in cybersecurity investments and revenue-driving products.

Phreesia Inc reports robust Q2 earnings and optimistic outlook

Phreesia Inc's Q2 2025 earnings call highlighted strong financial performance and positive outlook for fiscal 2025. While facing uncertainties around external factors and inorganic opportunities, the company remains focused on driving growth through AHSC expansion and revenue enhancement strategies.

Phreesia Inc reports robust Q3 earnings, eyes sustained growth

Phreesia Inc's Q3 performance reflects strong financial results and positive cash flows, underpinning its growth trajectory.
The company's revised outlooks for fiscal 2025 and initial guidance for 2026 signal confidence in sustained growth and profitability.
While balancing profitability and reinvestment poses challenges, Phreesia has opportunities to leverage network solutions, customer feedback, and strategic leadership for future growth.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Phreesia, Inc. engages in the provision of patient check-in solutions for medical practices. The firm offers appointments, clinical support, integration, registration, patient activation, analytics and reports, revenue cycle, patient surveys, and privacy and security products. Its solutions include health systems, multi-specialty, and federally qualified health centers (FQHCs). The company was founded by Chaim Indig and Evan Roberts in January 2005 and is headquartered in Wilmington, DE.

The consensus price target hints at a 25% upside potential for Phreesia (PHR). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Wall Street Analysts See a 25% Upside in Phreesia (PHR): Can the Stock Really Move This High?

Phreesia's Q3 earnings show solid revenue growth, but customer growth is decelerating, impacting overall performance. Fiscal 2025 guidance improved with higher EBITDA and tighter revenue estimates, while fiscal 2026 projects slower revenue growth but significant EBITDA improvement. Strong cash flow and disciplined expense management are encouraging, with the company maintaining positive cash flows and holding $82M in cash.

Phreesia Has Turned The Corner, Can It Continue To Mend?

Phreesia, Inc. (PHR) Q3 2025 Earnings Call Transcript

While the top- and bottom-line numbers for Phreesia (PHR) give a sense of how the business performed in the quarter ended October 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Phreesia (PHR) Reports Q3 Earnings: What Key Metrics Have to Say

Phreesia (PHR) came out with a quarterly loss of $0.25 per share versus the Zacks Consensus Estimate of a loss of $0.29. This compares to loss of $0.58 per share a year ago.

Phreesia (PHR) Reports Q3 Loss, Tops Revenue Estimates

ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia, Inc. (NYSE: PHR) (“Phreesia” or the "Company") announced financial results today for the fiscal third quarter ended October 31, 2024. "We are excited about the future here at Phreesia,” said CEO and Co-Founder Chaim Indig. “Our network continues to grow, adoption of our current offerings is increasing, and we are beginning to see the promise of new solutions we are investing in.” Please visit the Phreesia investor relations website.

Phreesia Announces Third Quarter Fiscal 2025 Results

Evaluate the expected performance of Phreesia (PHR) for the quarter ended October 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

Curious about Phreesia (PHR) Q3 Performance? Explore Wall Street Estimates for Key Metrics

ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia has been selected by The Software Report as one of the “Top 100 Software Companies of 2024” for a third consecutive year.

Phreesia Named to The Software Report's “Top 100 Software Companies” for the Third Consecutive Year

Phreesia (PHR) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Phreesia (PHR) Moves 13.9% Higher: Will This Strength Last?

ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia announced that it will release its fiscal third quarter 2025 financial results after the close of market trading on Monday, Dec. 9, 2024.

Phreesia Sets Release Date for Fiscal Third Quarter 2025 Results

ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia announced that it has achieved Oracle Validated Integration with Oracle Health EHR Expertise for its integration of the Phreesia platform.

Phreesia Achieves Oracle Validated Integration With Oracle Health EHR Expertise for Delivering Proven, Repeatable Integration

Phreesia (PHR) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

Down -10.25% in 4 Weeks, Here's Why Phreesia (PHR) Looks Ripe for a Turnaround

ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia has joined the NAI to shape the national conversation around data privacy and promote consumer choice and transparency.

Phreesia Joins the Network Advertising Initiative as a Member, Demonstrating Ongoing Commitment to Industry-Leading Privacy Practices

ALL-REMOTE COMPANY/WILMINGTON, Del. & NEW YORK--(BUSINESS WIRE)--Phreesia has collaborated with the Ad Council to bring three public health campaigns about mental health directly to patients and caregivers.

Phreesia and Ad Council Partnership Yields High Patient Engagement in 3 Mental Health Awareness Campaigns

ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia is pleased to announce that its contract with the CMS Innovation Center for use of the Patient Activation Measure® has been renewed to 2029.

Phreesia Secures New Contract With CMS as Report Shows Gains in Patient Activation in First Year of Kidney Care Choices (KCC) Model

ALL-REMOTE COMPANY/WILMINGTON, Del. & LAFAYETTE, Colo. & SAN FRANCISCO--(BUSINESS WIRE)--The CDC awards grant to Phreesia, NAFC, Health.Equity.Outcomes. and Christina Escobar, MD, at NYU, to combat urinary incontinence in women.

CDC Awards Grant to NAFC, Phreesia and Health.Equity.Outcomes. to Tackle Public Health Challenge of Urinary Incontinence

I maintain a buy rating for PHR, driven by strong client growth, solid revenue outlook, and increasing transaction sizes in the pipeline. PHR's 2Q25 results show 19% y/y revenue growth and improved profitability, with positive EBITDA and FCF, indicating strong financial health. Despite a slight decline in revenue per AHSC, larger client acquisitions and increased transaction sizes support my 20% growth expectation.

Phreesia: Remain Bullish Given The Healthy Growth Outlook

Phreesia, Inc. (NYSE:PHR ) Q2 2025 Earnings Conference Call September 4, 2024 5:00 PM ET Company Participants Balaji Gandhi - Chief Financial Officer Chaim Indig - Chief Executive Officer Conference Call Participants Anne Samuel - JPMorgan Ryan Daniels - William Blair Scott Schoenhaus - KeyBanc Jessica Tassan - Piper Sandler Jailendra Singh - Truist Securities Glen Santangelo - Jefferies Stephanie Davis - Barclays Joe Vruwink - Baird John Ransom - Raymond James Richard Close - Canaccord Security Daniel Grosslight - Citi Sean Dodge - RBC Capital Markets Jeff Garro - Stephens Matthew Shea - Needham & Company Jack Wallace - Guggenheim Aaron Kimson - Citizens JMP Operator Good evening, ladies and gentlemen, and welcome to the Phreesia Second Quarter Fiscal 2025 Earnings Conference Call. At this time all participants are in a listen-only mode.

Phreesia, Inc. (PHR) Q2 2025 Earnings Call Transcript

The headline numbers for Phreesia (PHR) give insight into how the company performed in the quarter ended July 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Phreesia (PHR) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Phreesia (PHR) came out with a quarterly loss of $0.31 per share versus the Zacks Consensus Estimate of a loss of $0.37. This compares to loss of $0.68 per share a year ago.

Phreesia (PHR) Reports Q2 Loss, Tops Revenue Estimates

ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia, Inc. (NYSE: PHR) (“Phreesia” or the "Company") announced financial results today for the fiscal second quarter ended July 31, 2024. "We reached another very important milestone in Phreesia's evolution by crossing over to positive Free cash flow1 in the fiscal second quarter of 2025,” said CEO and Co-Founder Chaim Indig. “We believe this milestone marks the start of a new era for Phreesia in which we are able to deploy internally ge.

Phreesia Announces Second Quarter Fiscal 2025 Results

Get a deeper insight into the potential performance of Phreesia (PHR) for the quarter ended July 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.

Phreesia (PHR) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures

NEW YORK, NY / ACCESSWIRE / August 29, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Phreesia, Inc. ("Phreesia") (NYSE:PHR) concerning possible violations of federal securities laws. Phreesia issued a press release on May 30, 2024, announcing financial results for the first quarter of its fiscal year 2025.

PHR ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Phreesia, Inc.

ALL-REMOTE COMPANY/WILMINGTON, Del. & ITASCA, Ill.--(BUSINESS WIRE)--Phreesia announces that it has teamed up with the American Academy of Pediatrics to help increase measles, mumps and rubella immunizations.

Phreesia and American Academy of Pediatrics Join in Campaign to Increase Childhood MMR Vaccination

NEW YORK, NY / ACCESSWIRE / August 28, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Phreesia, Inc. ("Phreesia") (NYSE:PHR) concerning possible violations of federal securities laws. Phreesia issued a press release on May 30, 2024, announcing financial results for the first quarter of its fiscal year 2025.

News for Phreesia Inc Stock (PHR)